MAPT and frontotemporal dementia: Other have targeted tau and NFTs (Musi et al., 2018), which have been associated with several diseases, including AD, FTD progressive supranuclear palsy, and corticobasal degeneration, and their roles in other neurodegenerative diseases remain under investigation (Ransohoff, 2016; Hou et al., 2019).